Editorial: HRPT2 in parathyroid cancer: A piece of the puzzle

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 9, 2005, Pages 5505-5507

  Rubin, Mishaela R ^a   Silverberg, Shonni J ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; GENE PRODUCT; PARAFIBROMIN; PARATHYROID HORMONE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; CALCIUM BLOOD LEVEL; CANCER SURGERY; CLINICAL FEATURE; EDITORIAL; GENETIC SCREENING; HRPT2 GENE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM JAW TUMOR SYNDROME; IMMUNORADIOMETRIC ASSAY; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; PARATHYROID TUMOR; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; THYROID SURGERY; TUMOR SUPPRESSOR GENE;

HUMANS; MUTATION; PARATHYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 24344504476     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-1578     Document Type: Editorial

References (13)

1. Shane E 2001 Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab 86:485-493
2. Albright F, Reifenstein E 1948 The parathyroid glands and metabolic bone disease. Baltimore: Williams, Wilkins
3. Schantz A, Castleman B 1973 Parathyroid carcinoma. A study of 70 cases. Cancer 31:600-605
4. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Hoog A, Heath 3rd H, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR 2002 HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676-680
5. Woodard GE, Lin L, Zhang JH, Agarwal SK, Marx SJ, Simonds WF 2005 Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene 24:1272-1276
6. Yart A, Gstaiger M, Wirbelauer C, Pecnik M, Anastasiou D, Hess D, Krek W 2005 The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol 25:5052-5060
7. Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Hammje K, Dralle H, Hoang-Vu C, Gimm O, Marsh DJ, Morreau H, Teh BT 2003 HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40:657-663
8. Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, ArnoldA2003 Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722-1729
9. Cetani F, Pardi E, Borsari S, Viacava P, Dipollina G, Cianferotti L, Ambrogini E, Gazzerro E, Colussi G, Berti P, Miccoli P, Pinchera A, Marcocci C 2004 Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 89:5583-5591
10. Tan MH, Morrison C, Wang P, Yang X, Haven CJ, Zhang C, Zhao P, Tretiakova MS, Korpi-Hyovalti E, Burgess JR, Soo KC, Cheah WK, Cao B, Resau J, Morreau H, Teh BT 2004 Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 10:6629-6637
11. Krebs LJ, Shattuck TM, Arnold A 2005 HRPT2 mutational analysis of typical sporadic parathyroid adenomas. J Clin Endocrinol Metab 90:5015-5017
12. Simonds WF, Robbins CM, Agarwal SK, Hendy GN, Carpten JD, Marx SJ 2004 Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 89:96-102
13. Teh BT, Farnebo F, Kristoffersson U, Sundelin B, Cardinal J, Axelson R, Yap A, Epstein M, Heath 3rd H, Cameron D, Larsson C 1996 Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab 81:4204-4211